Clinical Trial Update: ZP120 Add-on to Furosemide in Treatment of Acute or Sub-Acute Decompensated Heart Failure [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating ZP120 as an add-on to furosemide for acute or sub-acute decompensated heart failure was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• FUROSEMIDE (Furosemide)
• ZP120

Snippet

Sponsor: Zealand Pharma | Conditions: Heart Failure, Congestive | Phase 2 | Status: TERMINATED